Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
RXRX - Recursion Pharmaceuticals, Inc.
Market Cap 2.53B P/E - EPS this Y -2.50% Ern Qtrly Grth -
Income -374.93M Forward P/E -8.23 EPS next Y -10.50% 50D Avg Chg 31.00%
Sales 49.63M PEG -0.37 EPS past 5Y - 200D Avg Chg 55.00%
Dividend N/A Price/Book 5.88 EPS next 5Y 12.00% 52W High Chg -21.00%
Recommedations 2.70 Quick Ratio 5.54 Shares Outstanding 275.07M 52W Low Chg 190.00%
Insider Own 4.55% ROA -34.35% Shares Float 245.45M Beta 0.81
Inst Own 87.46% ROE -71.18% Shares Shorted/Prior 59.16M/54.15M Price 13.17
Gross Margin - Profit Margin - Avg. Volume 5,772,806 Target Price 9.44
Oper. Margin -697.39% Earnings Date Nov 7 Volume 4,541,377 Change -4.67%
Healthcare | Biotechnology | United States
About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Recursion Pharmaceuticals, Inc. News
11/20/24 Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
11/15/24 Nvidia Discloses Stake In Applied Digital, Keeps Arm, SoundHound Stakes
11/13/24 Recursion and Exscientia Shareholders Approve the Proposed Combination
11/12/24 Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden
11/10/24 Analysts' Revenue Estimates For Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Are Surging Higher
11/06/24 Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
11/06/24 Recursion Pharmaceuticals: Q3 Earnings Snapshot
11/06/24 Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
11/02/24 Is Recursion Pharmaceuticals a Millionaire-Maker Stock?
11/01/24 Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider
10/30/24 Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
10/30/24 Recursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th
10/26/24 3 Key Trends That Are Bullish for Recursion Pharmaceuticals Stock
10/24/24 Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know
10/23/24 Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech Innovation
10/22/24 Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
10/18/24 State Street Corp's Strategic Acquisition in the Biotechnology Sector
10/17/24 Prediction: These 2 Stocks Could Soar in 2025
10/15/24 Recursion Pharmaceuticals (RXRX) Stock Moves -0.74%: What You Should Know
10/15/24 Cathie Wood Is Betting on This AI Stock: Is It a Buy?
RXRX Chatroom

User Image HughGProtifts1 Posted - 56 minutes from now

$RXRX getchu some

User Image JasonJac Posted - 38 minutes from now

$RXRX I'm 8 for 8 on making money trading this stock over past 2 years. Havent entered in 10 months. I just entered today at 5.63. Actually hoping it goes down more so i can add.

User Image LoveRetailFroth Posted - 31 minutes from now

$RXRX Future Pharma getting slapped around like somebody’s Bit$h is Unreal🤦‍♂️

User Image BillyBarue Posted - 30 minutes from now

$RXRX shouldn’t have to work this hard to get to 6 😂

User Image youmobilized Posted - 17 minutes from now

$RXRX It will payoff very soon. Patience is golden.

User Image nofunanymore Posted - 15 minutes from now

$RXRX Man this is just criminal what they are doing here. Hope shorts or funds read these posts cause I am calling the sec to have them look into the absolute blatant manipulation here. Maybe they'll get smacked.

User Image Tl5000 Posted - 1 minute from now

$RXRX give us some news!! Shares Short (10/31/2024) 4 62.43M Short Ratio (10/31/2024) 4 14.8 Short % of Float (10/31/2024) 4 24.56%

User Image Skipper777 Posted - 3 minutes ago

$RXRX

User Image Deggie Posted - 4 minutes ago

$RXRX stop selling and let it go long.

User Image AdjinCan Posted - 24 minutes ago

$RXRX added more here. Hope we all do well. 😀

User Image nofunanymore Posted - 1 hour ago

$RXRX Everything on fire! This is next! Buy if you can. EVERYONE ELSE JUST HOLD, HOLD AND WE GO HIGHER. SIMPLE AS THAT. HOLD

User Image escuintla Posted - 1 hour ago

$RXRX check $ALT

User Image jonym Posted - 1 hour ago

$RXRX nibble in

User Image exalance Posted - 1 hour ago

$RXRX

User Image Skipper777 Posted - 1 hour ago

$RXRX one more thought, if you just so happen to be exposing yourself to a squeeze 🍋 not saying any of you are… of course not 😅. But take a look at $VKTX , let that resonate, what can happen overnight in this industry. That would be a fun one to try and cover.

User Image moneybag888 Posted - 1 hour ago

$VSAT $RXRX $HNST

User Image Bigtyma3188 Posted - 1 hour ago

$RXRX these insiders selling constantly is really annoying

User Image sneeds_feed_N_seed Posted - 2 hours ago

$RXRX When???

User Image nofunanymore Posted - 2 hours ago

$RXRX think so but hope this hits $20 for you

User Image Skipper777 Posted - 2 hours ago

$RXRX last message of the day I have to keep working to buy more. Figured I would go all 1’s bought another 111 shares. 111,111 now. Its good luck for all us Class A Common guys. Yes I’ve lost my mind. 😁

User Image Bullshyte Posted - 3 hours ago

$RXRX short scum at it again. I hope the fckers burn in hell when this turns. And it will, violently...

User Image Skipper777 Posted - 3 hours ago

$RXRX 111,000 strong now, long term, if you are looking to get rich in a week or are short, you eventually will get hammered.

User Image Beachtrade10 Posted - 3 hours ago

$RXRX shorts had a good breakfast on this one....

User Image Skipper777 Posted - 3 hours ago

$RXRX

User Image McCartney Posted - 3 hours ago

$RXRX Frustrating...just like you have always sell yourself in life to move forward, this company does nothing to sell itself. Investor relations is pathetic.

User Image Etrading Posted - 3 hours ago

$RXRX I told you guys especially those who invested almost 1M $$.. too many share now after merge and that $8.50 pump was great area to take profit...

User Image nofunanymore Posted - 3 hours ago

$RXRX gets worse and worse

User Image undyingzor Posted - 3 hours ago

$RXRX RFK don't believe in vaccines, this is done. Maybe come back in 4 years when it sin pennies, then it's a good play

User Image nofunanymore Posted - 3 hours ago

$RXRX truly pathetic

User Image jimbob3369 Posted - 3 hours ago

$RXRX this could have to do with the merger as well.

Analyst Ratings
Needham Buy Sep 4, 24
Jefferies Hold Sep 3, 24
Leerink Partners Market Perform Sep 3, 24
Needham Buy Aug 9, 24
Keybanc Overweight Jul 11, 24
Needham Buy Jun 25, 24
Needham Buy May 10, 24
Needham Buy Apr 9, 24
Keybanc Overweight Mar 4, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Larson Tina Marriott President and COO President and COO Jan 25 Sell 10.35 8,000 82,800 414,548 01/29/24
Larson Tina Marriott President and COO President and COO Jan 25 Option 1.06 8,000 8,480 422,584 01/29/24
Borgeson Blake Director Director Jan 23 Sell 10.5756 20,054 212,083 7,324,364 01/25/24
Virani Shafique Chief Business Offic.. Chief Business Officer Jan 16 Sell 10.93 18,000 196,740 136,748 01/18/24
Virani Shafique Chief Business Offic.. Chief Business Officer Jan 16 Option 2.22 18,000 39,960 154,748 01/18/24
Secora Michael Chief Financial Offi.. Chief Financial Officer Jan 16 Sell 10.35 50,000 517,500 981,014 01/18/24
Secora Michael Chief Financial Offi.. Chief Financial Officer Jan 16 Option 2.22 75,000 166,500 1,006,014 01/18/24
Li Dean Y Director Director Jan 09 Sell 13.84 29,000 401,360 421,000 01/11/24
Borgeson Blake Director Director Jan 09 Sell 13.51 20,054 270,930 7,344,418 01/11/24
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Jan 03 Sell 9.5 55,853 530,604 01/05/24
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Jan 03 Option 2.48 31,250 77,500 822,578 01/05/24
Larson Tina Marriott President and COO President and COO Dec 28 Option 1.06 8,000 8,480 422,548 01/02/24
Larson Tina Marriott President and COO President and COO Dec 28 Sell 10.58 8,000 84,640 414,548 01/02/24
Borgeson Blake Director Director Dec 26 Sell 10.6285 20,054 213,144 7,364,472 12/28/23
Virani Shafique Chief Business Offic.. Chief Business Officer Dec 15 Sell 9.6 18,000 172,800 136,748 12/19/23
Virani Shafique Chief Business Offic.. Chief Business Officer Dec 15 Option 2.22 18,000 39,960 154,748 12/19/23
Dar Zavain Director Director Dec 14 Sell 9.00 20,141 181,269 53,823 12/18/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Dec 12 Sell 7.49 50,000 374,500 956,014 12/14/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Dec 12 Option 2.22 75,000 166,500 981,014 12/14/23
Borgeson Blake Director Director Dec 12 Sell 7.3987 11,447 84,693 7,384,526 12/14/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Dec 06 Sell 7.49 59,829 448,119 791,328 12/08/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Dec 06 Option 2.48 31,250 77,500 851,157 12/08/23
Borgeson Blake Director Director Nov 28 Sell 6.7195 11,447 76,918 7,395,973 11/30/23
Larson Tina Marriott President and COO President and COO Nov 15 Sell 6.76 3,000 20,280 413,404 11/17/23
Larson Tina Marriott President and COO President and COO Nov 15 Option 1.06 3,000 3,180 416,404 11/17/23
Virani Shafique Chief Business Offic.. Chief Business Officer Nov 15 Sell 6.51 18,000 117,180 140,351 11/17/23
Virani Shafique Chief Business Offic.. Chief Business Officer Nov 15 Option 2.22 18,000 39,960 158,351 11/17/23
Borgeson Blake Director Director Nov 14 Sell 6.3197 8,885 56,151 7,407,420 11/16/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Nov 14 Sell 7.06 50,000 353,000 938,186 11/16/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Nov 14 Option 2.22 75,000 166,500 963,186 11/16/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Nov 01 Sell 5.15 62,177 320,212 11/03/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Nov 01 Option 2.48 31,250 77,500 873,997 11/03/23
Borgeson Blake Director Director Oct 31 Sell 5.2745 8,885 46,864 7,416,305 11/02/23
Larson Tina Marriott President and COO President and COO Oct 26 Sell 5.63 3,000 16,890 418,782 10/30/23
Larson Tina Marriott President and COO President and COO Oct 26 Option 1.06 3,000 3,180 421,782 10/30/23
Borgeson Blake Director Director Oct 17 Sell 6.5822 8,885 58,483 7,425,190 10/19/23
Virani Shafique Chief Business Offic.. Chief Business Officer Oct 16 Sell 6.3 18,000 113,400 140,351 10/18/23
Virani Shafique Chief Business Offic.. Chief Business Officer Oct 16 Option 2.22 18,000 39,960 158,351 10/18/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Oct 10 Sell 6.96 50,000 348,000 913,186 10/12/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Oct 10 Option 2.22 75,000 166,500 938,186 10/12/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Oct 04 Sell 7.21 59,794 431,115 842,747 10/06/23
Gibson Christopher Chief Executive Offi.. Chief Executive Officer Oct 04 Option 2.48 31,250 77,500 902,541 10/06/23
Borgeson Blake Director Director Oct 03 Sell 7.2907 8,885 64,778 7,434,075 10/05/23
Larson Tina Marriott President and COO President and COO Sep 28 Sell 7.72 3,000 23,160 418,782 10/02/23
Larson Tina Marriott President and COO President and COO Sep 28 Option 1.06 3,000 3,180 421,782 10/02/23
Borgeson Blake Director Director Sep 19 Sell 8.3599 8,885 74,278 7,442,960 09/21/23
Virani Shafique Chief Business Offic.. Chief Business Officer Sep 15 Sell 8.66 18,000 155,880 140,351 09/19/23
Virani Shafique Chief Business Offic.. Chief Business Officer Sep 15 Option 2.22 18,000 39,960 158,351 09/19/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Sep 12 Sell 8.56 50,000 428,000 888,186 09/14/23
Secora Michael Chief Financial Offi.. Chief Financial Officer Sep 12 Option 2.22 75,000 166,500 913,186 09/14/23